Company profile for Ligand Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Our business model creates value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Our goal is to offer investors an opportunity to participate in th...
Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Our business model creates value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Our goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable, diversified and lower-risk business than a typical biotech company.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
3911, Sorrento Valley Boulevard, Suite 110, San Diego, CA 92121
Telephone
Telephone
+1 858-550-7500
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/09/3202202/0/en/Ligand-Hosts-2025-Investor-Day-and-Introduces-2026-Guidance.html

GLOBENEWSWIRE
09 Dec 2025

https://www.globenewswire.com/news-release/2025/10/30/3177879/0/en/Ligand-to-Participate-in-November-Investor-Conferences.html

GLOBENEWSWIRE
30 Oct 2025

https://www.globenewswire.com/news-release/2025/10/23/3171881/0/en/Ligand-to-Report-Third-Quarter-2025-Financial-Results-on-November-6-2025.html

GLOBENEWSWIRE
23 Oct 2025

https://www.globenewswire.com/news-release/2025/10/16/3167785/0/en/Ligand-to-Host-Investor-Day-on-December-9-2025.html

GLOBENEWSWIRE
16 Oct 2025

https://www.globenewswire.com/news-release/2025/10/09/3164011/0/en/Ligand-Partner-SQ-Innovation-Receives-FDA-Approval-for-Lasix-ONYU-an-At-Home-Treatment-for-Edema-in-Heart-Failure-Patients.html

GLOBENEWSWIRE
09 Oct 2025

https://www.globenewswire.com/news-release/2025/08/19/3135989/0/en/Ligand-to-Participate-in-September-Investor-Conferences.html

GLOBENEWSWIRE
19 Aug 2025

Excipients

Click here to find the perfect excipient manufacturers by their capabilities

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty